Stock Analysis on Net

Biogen Inc. (NASDAQ:BIIB)

$22.49

This company has been moved to the archive! The financial data has not been updated since October 25, 2022.

Net Profit Margin
since 2005

Microsoft Excel

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Biogen Inc., net profit margin, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in thousands


Net Income Attributable to Biogen Inc.
The net income showed a consistent upward trend from 2005 through 2014, rising from approximately $161 million to around $3.5 billion. This growth was particularly pronounced between 2011 and 2014. After peaking in 2015 and 2016 at around $3.7 billion, net income experienced volatility with a significant dip in 2017 to $2.54 billion, followed by a strong recovery in 2018 and 2019, reaching the highest value of roughly $5.89 billion in 2019. However, this peak was followed by a noticeable decline in the subsequent years, dropping to $4.0 billion in 2020 and further to about $1.56 billion in 2021.
Revenues
Revenues exhibited steady growth from 2005 to 2014, increasing from approximately $2.42 billion to $10.76 billion. The increase accelerated significantly after 2011, with revenues surpassing $13 billion in 2018 and reaching their highest level of about $14.38 billion in 2019. Afterward, revenues declined to approximately $13.45 billion in 2020 and further to $10.98 billion in 2021, indicating a reversal in the previous growth trend during these two years.
Net Profit Margin
The net profit margin improved substantially over the decade, starting at 6.63% in 2005 and reaching over 30% from 2013 to 2016, peaking at 32.95% in 2014. Thereafter, it showed fluctuations, with a marked decrease to 20.69% in 2017, followed by a rebound to 32.93% in 2018 and its highest margin of 40.96% in 2019. The margin then declined noticeably in the last two years of the data, dropping to 29.76% in 2020 and further to 14.17% in 2021. This decline corresponds with the decreases observed in net income and revenues in the same period.
Overall Insights
The data reveals a period of strong financial growth from 2005 to 2014, characterized by increasing revenues, net income, and improving profit margins. The company reached its peak financial performance around 2019, followed by a marked downturn in 2020 and 2021. The declines in net income and revenues during these years, alongside the decreasing profit margins, suggest challenges impacting profitability and top-line growth, potentially warranting further investigation into underlying causes.

Comparison to Competitors

Biogen Inc., net profit margin, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)

Biogen Inc., net profit margin, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)

Microsoft Excel

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Industry (Health Care)